FTC sues drug middlemen for allegedly inflating insulin prices

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *